Immunology
-
Isolation of potent SARS-CoV-2 neutralizing antibodies and protection from disease in a small animal model
This article has 34 authors:Reviewed by ScreenIT
-
Identification of neutralizing human monoclonal antibodies from Italian Covid-19 convalescent patients
This article has 23 authors:Reviewed by ScreenIT
-
Development of a Vaccine against SARS-CoV-2 Based on the Receptor-Binding Domain Displayed on Virus-Like Particles
This article has 15 authors:Reviewed by ScreenIT
-
Low Baseline Pulmonary Levels of Cytotoxic Lymphocytes as a Predisposing Risk Factor for Severe COVID-19
This article has 1 author:Reviewed by ScreenIT
-
Computational methods to develop potential neutralizing antibody Fab region against SARS-CoV-2 as therapeutic and diagnostic tool
This article has 2 authors:Reviewed by ScreenIT
-
Neutralizing Antibodies Isolated by a site-directed Screening have Potent Protection on SARS-CoV-2 Infection
This article has 10 authors:Reviewed by ScreenIT
-
Estimating the cumulative incidence of SARS-CoV-2 with imperfect serological tests: Exploiting cutoff-free approaches
This article has 4 authors:Reviewed by ScreenIT
-
Validation of a SARS-CoV-2 spike protein ELISA for use in contact investigations and sero-surveillance
This article has 18 authors:Reviewed by ScreenIT
-
Recombinant SARS-CoV-2 spike S1-Fc fusion protein induced high levels of neutralizing responses in nonhuman primates
This article has 24 authors:Reviewed by ScreenIT
-
This article has 4 authors:
Reviewed by ScreenIT